The spectrum of malignancy in craniopharyngioma

American Journal of Surgical Pathology

Volumn 31, Issue 7, 2007, Pages 1020-1028

  Rodriguez, Fausto J ^a   Scheithauer, Bernd W ^a   Tsunoda, Shigeru ^b   Kovacs, Kalman ^c   Vidal, Sergio ^d   Piepgras, David G ^a  

^a MAYO CLINIC   (United States)

^b Osaka Prefecture University   (Japan)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Craniopharyngioma; Ghost cell carcinoma; Malignant transformation; Myoepithelioma; Odontogenic; Squamous cell carcinoma; Suprasellar

Indexed keywords

HEMATOXYLIN; KI 67 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRANIOPHARYNGIOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; MENINGIOMA; MICROVASCULATURE; MYOEPITHELIUM CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; ODONTOGENIC TUMOR; OUTCOME ASSESSMENT; SQUAMOUS CELL CARCINOMA; TIME OF DEATH; TUMOR RECURRENCE;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; COMBINED MODALITY THERAPY; CRANIOPHARYNGIOMA; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PITUITARY NEOPLASMS; RADIOTHERAPY, ADJUVANT; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES;

EID: 34347351251     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31802d8a96     Document Type: Article

References (61)

1. Akachi K, Takahashi H, Ishijima B, et al. Malignant changes in a craniopharyngioma. No Shinkei Geka. 1987;15:843-848.
2. Alvarez-Garijo JA, Froufe A, Taboada D, et al. Successful surgical treatment of an odontogenic ossified craniopharyngioma. Case report. J Neurosurg. 1981;55:832-835.
3. Badger KV, Gardner DG. The relationship of adamantinomatous craniopharyngioma to ghost cell ameloblastoma of the jaws: a histopathologic and immunohistochemical study. J Oral Pathol Med. 1997;26:349-355.
4. Bernstein ML, Buchino JJ. The histologic similarity between craniopharyngioma and odontogenic lesions: a reappraisal. Oral Surg Oral Med Oral Pathol. 1983;56:502-511.
5. Broggi G, Franzini A, Cajola L, et al. Cell kinetic investigations in craniopharyngioma: preliminary results and considerations. Pediatr Neurosurg. 1994;21(suppl 1):21-23.
6. Burger PC, Scheithauer BW, Vogel FS. Surgical Pathology of the Nervous System and Its Coverings. New York: Churchill Livingstone; 2002.
7. Castle JT, Arendt DM. Aggressive (malignant) epithelial odontogenic ghost cell tumor. Ann Diagn Pathol. 1999;3:243-248.
8. Cheng Y, Long X, Li X, et al. Clinical and radiological features of odontogenic ghost cell carcinoma: review of the literature and report of four new cases. Dentomaxillofac Radiol. 2004;33:152-157.
9. Conklin JL. The development of the human fetal adenohypophysis. Anat Rec. 1968;160:79-91.
10. Crotty TB, Scheithauer BW, Young WF Jr, et al. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg. 1995;83:206-214.
11. Eldevik OP, Blaivas M, Gabrielsen TO, et al. Craniopharyngioma: radiologic and histologic findings and recurrence. AJNR Am J Neuroradiol. 1996;17:1427-1439.
12. Elmaci L, Kurtkaya-Yapicier O, Ekinci G, et al. Metastatic papillary craniopharyngioma: case study and study of tumor angiogenesis. Neuro-oncol. 2002;4:123-128.
13. Esposito I, Menicagli M, Funel N, et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol. 2004;57:630-636.
14. Falin LI. The development of human hypophysis and differentiation of cells of its anterior lobe during embryonic life. Acta Anat (Basel). 1961;44:188-205.
15. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-31.
16. Folpe AL, Tsue T, Rogerson L, et al. Odontogenic ghost cell carcinoma: a case report with immunohistochemical and ultrastructural characterization. J Oral Pathol Med. 1998;27:185-189.
17. Giangaspero F, Burger PC, Osborne DR, et al. Suprasellar papillary squamous epithelioma ("papillary craniopharyngioma"). Am J Surg Pathol. 1984;8:57-64.
18. Goldenberg D, Sciubba J, Tufano RP. Odontogenic ghost cell carcinoma. Head Neck. 2004;26:378-381.
19. Graziani N, Donnet A, Bugha TN, et al. Ectopic basisphenoidal craniopharyngioma: case report and review of the literature. Neurosurgery. 1994;34:346-349; discussion 349.
20. Grover WD, Rorke LB. Invasive craniopharyngioma. J Neurol Neurosurg Psychiatry. 1968;31:580-582.
21. Gupta K, Kuhn MJ, Shevlin DW, et al. Metastatic craniopharyngioma. AJNR Am J Neuroradiol. 1999;20:1059-1060.
22. Hampton TA, Scheithauer BW, Rojiani AM, et al. Salivary gland-like tumors of the sellar region. Am J Surg Pathol. 1997;21:424-434.
23. Hassanein AM, Glanz SM, Kessler HP, et al. beta-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst. Am J Clin Pathol. 2003;120:732-736.
24. Honegger J, Renner C, Fahlbusch R, et al. Progesterone receptor gene expression in craniopharyngiomas and evidence for biological activity. Neurosurgery. 1997;41:1359-1363; discussion 1363-1364.
25. Ito M, Jamshidi J, Yamanaka K. Does craniopharyngioma metastasize? Case report and review of the literature. Neurosurgery. 2001;48:933-935; discussion 935-936.
26. Izumoto S, Suzuki T, Kinoshita M, et al. Immunohistochemical detection of female sex hormone receptors in craniopharyngiomas: correlation with clinical and histologic features. Surg Neurol. 2005;63:520-525; discussion 525.
27. Jallu A, Rahm B, Kanaan I, et al. Pituitary tooth: case report of a suprasellar teratoma. Childs Nerv Syst. 1990;6:368-369.
28. Janzer RC, Burger PC, Giangaspero F, et al. Craniopharyngioma. In: Kleihues P, Cavenee WK, eds. Tumors of the Nervous System. Lyon: IARC Press; 2000:244-246.
29. Kamijo R, Miyaoka K, Tachikawa T, et al. Odontogenic ghost cell carcinoma: report of a case. J Oral Maxillofac Surg. 1999;57:1266-1270.
30. Kawamata T, Kubo O, Kamikawa S, et al. Ectopic clival craniopharyngioma. Acta Neurochir (Wien). 2002;144:1221-1224.
31. Kim J, Lee EH, Yook JI, et al. Odontogenic ghost cell carcinoma: a case report with reference to the relation between apoptosis and ghost cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:630-635.
32. Kleinschmidt-DeMasters BK, Pflaumer SM, Mulgrew TD, et al. Sinonasal teratocarcinosarcoma ("mixed olfactory neuroblastoma- craniopharyngioma") presenting with syndrome of inappropriate secretion of antidiuretic hormone. Clin Neuropathol. 2000;19:63-69.
33. Konovalov AN, Lichterman BL, Korshunov AG. Endo-suprasellar teratoma with teeth formation. Case report. Acta Neurochir (Wien). 1992;118:181-184.
34. Kristopaitis T, Thomas C, Petruzzelli GJ, et al. Malignant craniopharyngioma. Arch Pathol Lab Med. 2000;124:1356-1360.
35. Lee DK, Jung HW, Kim DG, et al. Postoperative spinal seeding of craniopharyngioma. Case report. J Neurosurg. 2001;94:617-620.
36. Lloyd RV, Scheithauer BW, Kuroki T, et al. Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol. 1999;10:229-235.
37. Lu Y, Mock D, Takata T, et al. Odontogenic ghost cell carcinoma: report of four new cases and review of the literature. J Oral Pathol Med. 1999;28:323-329.
38. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med. 1995;1:686-692.
39. Naresh KN, Pai SA. Foci resembling olfactory neuroblastoma and craniopharyngioma are seen in sinonasal teratocarcinosarcomas. Histopathology. 1998;32:84.
40. Nelson GA, Bastian FO, Schlitt M, et al. Malignant transformation in craniopharyngioma. Neurosurgery. 1988;22:427-429.
41. Nielsen GP, Stemmer-Rachamimov AO, Ino Y, et al. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am J Pathol. 1999;155:1879-1884.
42. Nishi T, Kuratsu J, Takeshima H, et al. Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma. Int J Mol Med. 1999;3:157-161.
43. Nishioka H, Ito H, Haraoka J, et al. Immature teratoma originating from the pituitary gland: case report. Neurosurgery. 1999;44:644-647; discussion 647-648.
44. Pace V, Heider K, Persohn E, et al. Spontaneous malignant craniopharyngioma in an albino rat. Vet Pathol. 1997;34:146-149.
45. Paulus W, Stockel C, Krauss J, et al. Odontogenic classification of craniopharyngiomas: a clinicopathological study of 54 cases. Histopathology. 1997;30:172-176.
46. Plowman PN, Besser GM, Shipley J, et al. Dramatic response of malignant craniopharyngioma to cis-platin-based chemotherapy. Should craniopharyngioma be considered as a suprasellar 'germ cell' tumour? Br J Neurosurg. 2004;18:500-505.
47. Ruebel KH, Jin L, Zhang S, et al. Inactivation of the p16 gene in human pituitary nonfunctioning tumors by hypermethylation is more common in null cell adenomas. Endocr Pathol. 2001;12:281-289.
48. Russell DS, Rubinstein LJ. Pathology of Tumours of the Nervous System. 5th ed. Baltimore: Williams & Wilkins; 1989.
49. Saxe SJ, Grossniklaus HE, Someren AO. Malignant myoepithelioma after radiation for retinoblastoma. Am J Ophthalmol. 1992;114:512-513.
50. Sciubba JJ, Fantasia JE, Kahn LB. Tumors and Cysts of the Jaw. Washington, DC: Armed Forces Institute of Pathology; 2001.
51. Seemayer TA, Blundell JS, Wiglesworth FW. Pituitary craniopharyngioma with tooth formation. Cancer. 1972;29:423-430.
52. Sekine S, Shibata T, Kokubu A, et al. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol. 2002;161:1997-2001.
53. Sekine S, Takata T, Shibata T, et al. Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation. Histopathology. 2004;45:573-579.
54. Subramani Iyer CG. Case report of an adamantinoma present at birth. J Neurosurg. 1952;9:221-228.
55. Suzuki F, Konuma I,Matsumoto M, et al. Craniopharyngioma with malignant transformation - a report of two cases. Gan No Rinsho. 1989;35:723-728.
56. Takigami M, Uede T, Imaizumi T, et al. A case of adenomatoid odontogenic tumor with intracranial extension. No Shinkei Geka. 1988;16:775-779.
57. Thapar K, Stefaneanu L, Kovacs K, et al. Estrogen receptor gene expression in craniopharyngiomas: an in situ hybridization study. Neurosurgery. 1994;35:1012-1017.
58. Ueki K, Ono Y, Henson JW, et al. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res. 1996;56:150-153.
59. Vidal S, Kovacs K, Lloyd RV, et al. Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome. Cancer. 2002;94:738-745.
60. Weiner HL, Wisoff JH, Rosenberg ME, et al. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery. 1994;35:1001-1010; discussion 1010-1011.
61. Yasargil MG, Curcic M, Kis M, et al. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg. 1990;73:3-11.